Dr. Michelle Pei-Yu Lin, MD

Dr. Lin practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Lin's NPI, 1568738383, was assigned on March 26, 2012. Dr. Lin graduated from University Of Washington School Of Medicine in 2016. Dr. Lin holds Florida license ME136432.

Dr. Lin's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Lin's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville. Dmand AI also links Dr. Lin to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Lin is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Lin's licenses on file in 10 states: Florida, Michigan, Arizona, Georgia, Pennsylvania, Iowa, Minnesota, Wisconsin, California and Maryland.

Dmand AI lists acute mini-stroke (TIA), cerebrovascular disease, epilepsy, lower back pain, migraine and chronic headache, mini-stroke (TIA), muscle weakness and non-alzheimer's dementia (chronic) among the conditions Dr. Lin treats.

CMS data shows 756 Medicare services from Dr. Lin across 13 procedure codes in 2024, for 455 Medicare patients. Medicare paid $79,618 for them.

CMS counts 455 Medicare patients who saw Dr. Lin in 2024. The largest group is 75 to 84, with 176 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 72, with 48% women.

In 2024, Dr. Lin wrote 407 Medicare Part D claims for 110 patients. 83% of them were for generic drugs. CMS names the drug for 290 of them, across 10 drugs with 11 or more claims each, at $51,717 in total drug cost. In 2023, CMS named 96 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Lin for performance year 2024, reported as part of a group. Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth.

Dmand AI links 147 papers to Dr. Lin, published from 2011 to 2025. 2020 was the busiest year, with 17. The most frequent topics are Emergency Medicine, Internship and Residency and Emergency Service, Hospital. Dr. Lin has published most often in West J Emerg Med. Dr. Lin's most frequent co-authors are James F. Meschia, MD, Young Mi Erben, MD and Josephine Huang, MD.

Dmand AI links Dr. Lin to 3 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Carotid Stenosis, Carotid Artery Diseases and Ischemic Stroke. Columbia University sponsors the most, 2.

CMS Open Payments shows 22 general payments to Dr. Lin from 11 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 56% of the total. Alnylam Pharmaceuticals Inc. paid the most, $1,128.

Dmand AI lists 2 awards for Dr. Lin.

Dr. Lin graduated from University Of Washington School Of Medicine in 2016.

Dr. Lin is in network with 8 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. POS plans come from the most carriers, 5. Check the plan with the practice before a visit.